Skip to content

Comparison of steroid injection vs dextrose prolotherapy in patients with chronic lateral epicondylitis

Comparison of steroid injection vs dextrose prolotherapy effects in improvement of patients with chronic lateral epicondylitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170311033000N3
Enrollment
36
Registered
2018-02-17
Start date
2017-08-22
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic lateral epicondylitis. Lateral epicondylitis

Interventions

Intervention 1: Intervention group: One time injection of 2cc dextrose 16 % made from 4 cc dextrose 20% and 1 cc lidocaine 2% with blue needle by pepering technique in lateral epicondyle region. Inter

Sponsors

Physical Medicine and Rehabilitation Department of Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: All patient having lateral epicondylitis for atleast 3 months All patients having chronic lateral epicondylitis with age range 18 -55 years old All patients having chronic lateral epicondylitis with Cozen positive test All patients having lateral epicondylitis didnt answer to conservative treatment

Exclusion criteria

Exclusion criteria: Any kind of injection about the involved elbow during previous 3months C6,C7 radiculopathy in the involved upper limb Cuagulopathy or using anti cuagulants diabetes melitus pregnancy surgery about the involved elbow during previous 3 months Rhumatologic disorder Recent trauma to the involved elbow since 3months ago

Design outcomes

Primary

MeasureTime frame
The pain intensity. Timepoint: Before injection , 1month and 3 months after the injection. Method of measurement: Asking patients to rate his/her pain in range of 0 -10 based on visual analogue scale.;The patient's function score. Timepoint: Before injection , 1month and 3 months after the injection. Method of measurement: Based on Quick DASH questionarie.;The patient's symptoms score. Timepoint: Before injection , 1month and 3 months after the injection. Method of measurement: Based on Quick DASH questionarie.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam alsadat Mortazavian Babaki

Shahid Beheshti University of Medical Sciences

maryam_m.babaky@sbmu.ac.ir+98 21 2207 4087

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 20, 2026